-
JPMorgan Steps To The Sidelines On Eastman Chemical
Monday, July 29, 2019 - 3:10pm | 350The case for being bullish on Eastman Chemical Company (NYSE: EMN) can no longer be justified due to contracting volumes and prices across Eastman's business portfolio, according to JPMorgan. The Analyst JPMorgan's Jeffrey Zekauskas downgraded Eastman Chemical from Overweight to Neutral...
-
JPMorgan Upgrades Mosaic After Stock Falls Close To 10-Year Low
Wednesday, May 8, 2019 - 10:47am | 358Mosaic Co (NYSE: MOS) stock has underperformed the market over the past one, three, five and 10 years, according to JPMorgan. Following this consistent underperformance, the sell-side firm said the stock now represents a positive trading opportunity, especially since the company has...
-
Chemours' 35% Drop In Titanium Dioxide Volume Sends JPMorgan To Sidelines
Monday, May 6, 2019 - 11:50am | 420Chemours Co (NYSE: CC) guided to a sharp year-on-year decline in titanium dioxide volumes in the second quarter. This not only marks the fourth consecutive quarter of decline, but also follows a massive 35-percent downturn recorded in the first quarter, according to JPMorgan. The Analyst Jeffrey...
-
Rising Costs Turn JPMorgan Bearish On LyondellBasell
Wednesday, September 19, 2018 - 10:51am | 346The bearish case for chemical company LyondellBasell Industries NV (NYSE: LYB) rests on expectations for declining financial performance in 2019, according to JPMorgan. The Analyst JPMorgan's Jeffrey Zekauskas downgraded LyondellBasell from Neutral to Underweight with a price...
-
Amazon Threat Turns JPMorgan Bearish On Valvoline
Friday, September 14, 2018 - 2:14pm | 375Reports of Amazon.com, Inc. (NASDAQ: AMZN) entering the motor oil business should be of particular concern for Valvoline Inc (NYSE: VVV) investors, according to JPMorgan. The Analyst JPMorgan's Jeffrey Zekauskas downgraded Valvoline from Neutral to Underweight with a price target lowered...
-
JPMorgan Projects Higher 2018 Sales In Axalta Upgrade
Friday, July 27, 2018 - 3:21pm | 360Axalta Coating Systems Ltd. (NYSE: AXTA) has promising growth opportunities, JPMorgan said in a Friday upgrade. The Analyst Analyst Jeffrey Zekauskas upgraded Axalta from Neutral to Overweight with a $33 price target. The Thesis Axalta is the most inexpensive of the major...
-
JPMorgan Turns Bullish On Mosaic Co. Thanks To Higher Commodity Prices
Wednesday, February 21, 2018 - 12:21pm | 375Mosaic Co (NYSE: MOS), a producer and marketer of concentrated phosphate and potash crop nutrients, stands to benefit from rising commodity costs that create a favorable risk-to-reward profile, according to JPMorgan. The Analyst JPMorgan's Jeffrey Zekauskas upgraded The Mosaic Company's...
-
The Simple Case For Being A Chemours Bull
Friday, May 12, 2017 - 10:51am | 543Outlining the investment case for Chemours Co (NYSE: CC), JPMorgan said the company has a proprietary set of very profitable newer generation refrigerants, with patent lives extending to 2022, with excellent growth potential. Riding On Regulatory Changes Analysts Jeffrey Zekauskas, Youyou Yan and...
-
News For The Weed-Kend: An Update On Marijuana Business And Policy
Friday, August 5, 2016 - 4:38pm | 522Friday is finally here, and media outlets are buzzing with marijuana news. From the DEA rumored to be on the brink of rescheduling the plant to coverage of candidates' positions on pot, weed news is growing like, well, weeds. So, let’s take a look into some of the most relevant marijuana news...
-
After A Downgrade In June, Dow Chemical Back To Overweight For JPMorgan
Friday, July 29, 2016 - 2:55pm | 367JPMorgan has upgraded Dow Chemical Co (NYSE: DOW) to Overweight, following its downgrade to Neutral in June on Brexit concerns. "The reports of our chemical companies concerning order patterns and business conditions in July suggest that European recessionary conditions are not a base case, and...
-
JPMorgan: Monsanto Shares Could Hit $180 Over The Next 5 Years
Tuesday, May 24, 2016 - 3:32pm | 401Monsanto Company (NYSE: MON) has rejected the $122 a share takeover offer from Germany's Bayer AG (ADR) (OTC: BAYRY), saying that the offer is "incomplete and financially inadequate." However, Monsanto is open to talks "to assess whether a transaction in the best interest of Monsanto shareowners...
-
JPMorgan Cuts Avery Dennison To Neutral
Friday, May 20, 2016 - 10:12am | 392JPMorgan has downgraded Avery Dennison Corp (NYSE: AVY) to Neutral from Overweight on "softening retail business trends" and recent share price gains. Shares of Glendale, California-based Avery Dennison, which makes pressure-sensitive products, have increased about 18 percent this year. 'Wait And...
-
Calls Of Note: Shake Shack, Kate Spade And Other Notable Research Notes Worth Following On Tuesday
Tuesday, August 11, 2015 - 10:53am | 1107The following represents a hand-picked selection of notable research curated by an analyst known in some circles as "The Sith Overlord Of The Street." Longbow: Shake Shack Trends ‘Picking Up,' Maintains At Neutral Alton Stump of Longbow Research maintained a Neutral rating on shares of Shake Shack...
-
UPDATE: Monsanto Gains After Upgrade from J.P. Morgan
Thursday, April 3, 2014 - 11:33am | 125J.P Morgan upgraded shares of Monsanto (NYSE: MON) from Neutral to Overweight and raised the price target from $115 to $125. The upgrade comes one day after the company reported upbeat second quarter earnings. Analyst Jeffrey Zekauskas sees opportunities for Monsanto to create shareholder value...
-
UPDATE: J.P. Morgan Reiterates On Valspar On F2014 EBITDA And Earnings Estimates
Wednesday, November 20, 2013 - 10:19am | 198In a report published Wednesday, J.P. Morgan analyst Jeffery Zekauskas reiterated a Neutral rating on Valspar (NYSE: VAL) but lowered the price target from $71.00 to $70.00. In the report, J.P.Morgan says "We reduced our F2014 EPS estimate for Valspar from $4.25 to $4.10 to reflect a lower level...